Centenial Surgical Suture Ltd. (BOM:531380)
97.50
+3.50 (3.72%)
At close: Aug 21, 2026
Centenial Surgical Suture Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 356 | 278 | 401 | 333 | 225 | 222 | |
Market Cap Growth | -39.04% | -30.66% | 20.42% | 48.13% | 1.51% | 42.10% |
Enterprise Value | 657 | 596 | 619 | 329 | 386 | 304 |
Last Close Price | 97.50 | 76.27 | 110.00 | 91.35 | 61.67 | 60.75 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | - | - | 29.38 | 25.40 | 35.34 |
PS Ratio | 0.63 | 0.52 | 0.75 | 0.65 | 0.43 | 0.50 |
PB Ratio | 1.25 | 0.98 | 1.31 | 1.03 | 0.72 | 0.73 |
P/TBV Ratio | 1.25 | 0.98 | 1.31 | 1.03 | 0.72 | 0.73 |
P/FCF Ratio | 7.04 | 5.51 | 7.16 | - | 19.84 | 4.83 |
P/OCF Ratio | 4.89 | 3.82 | 2.35 | 5.36 | 17.37 | 4.67 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.17 | 1.11 | 1.16 | 0.64 | 0.73 | 0.68 |
EV/EBITDA Ratio | 10.62 | 11.71 | 11.17 | 6.57 | 10.78 | 8.21 |
EV/EBIT Ratio | 31.69 | 54.66 | 30.84 | 9.09 | 12.87 | 10.40 |
EV/FCF Ratio | 13.02 | 11.80 | 11.05 | - | 34.01 | 6.62 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.06 | 1.06 | 1.09 | 0.86 | 0.48 | 0.49 |
Debt / EBITDA Ratio | 4.90 | 5.97 | 5.35 | 5.52 | 3.49 | 3.36 |
Debt / FCF Ratio | - | 6.01 | 5.98 | - | 13.21 | 3.25 |
Net Debt / Equity Ratio | 1.06 | 1.06 | 1.08 | 0.84 | 0.47 | 0.49 |
Net Debt / EBITDA Ratio | 4.87 | 5.93 | 6.01 | 5.38 | 4.10 | 3.96 |
Net Debt / FCF Ratio | - | 5.97 | 5.94 | -18.17 | 12.92 | 3.19 |
Asset Turnover | - | 0.66 | 0.65 | 0.70 | 0.82 | 0.68 |
Inventory Turnover | - | 0.45 | 0.40 | 0.43 | 0.58 | 0.57 |
Quick Ratio | - | 0.59 | 0.59 | 0.59 | 0.72 | 0.82 |
Current Ratio | - | 1.90 | 1.98 | 1.99 | 2.04 | 2.20 |
Return on Equity (ROE) | - | -7.43% | -4.65% | 3.58% | 2.89% | 2.10% |
Return on Assets (ROA) | - | 0.83% | 1.53% | 3.10% | 2.93% | 2.78% |
Return on Invested Capital (ROIC) | 3.55% | 1.78% | 3.26% | 6.14% | 4.01% | 3.64% |
Return on Capital Employed (ROCE) | - | 2.30% | 3.80% | 7.80% | 8.00% | 7.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -4.02% | -7.92% | -3.65% | 3.40% | 3.94% | 2.83% |
FCF Yield | 14.20% | 18.15% | 13.97% | -4.45% | 5.04% | 20.73% |
Buyback Yield / Dilution | -1.32% | -0.05% | - | - | - | - |